Literature DB >> 25399580

Neuropilin regulation of angiogenesis.

Anastasia Lampropoulou1, Christiana Ruhrberg1.   

Abstract

Blood vessel formation during vertebrate development relies on a process called angiogenesis and is essential for organ growth and tissue viability. In addition, angiogenesis leads to pathological blood vessel growth in diseases with tissue ischaemia, such as neovascular eye disease and cancer. Neuropilin 1 (NRP1) is a transmembrane protein that serves as a receptor for the VEGF₁₆₅ isoform of the vascular endothelial growth factor (VEGF) to enhance cell migration during angiogenesis via VEGF receptor 2 (VEGFR2), and it is also essential for VEGF-induced vascular permeability and arteriogenesis. In addition, NRP1 activation affects angiogenesis independently of VEGF signalling by activating the intracellular kinase ABL1. NRP1 also acts as a receptor for the class 3 semaphorin (SEMA3A) to regulate vessel maturation during tumour angiogenesis and vascular permeability in eye disease. In the present paper, we review current knowledge of NRP1 regulation during angiogenesis and vascular pathology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399580     DOI: 10.1042/BST20140244

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  42 in total

Review 1.  Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis.

Authors:  Chenxi Hu; Xiaodong Jiang
Journal:  Target Oncol       Date:  2016-08       Impact factor: 4.493

2.  Annexin A3 is necessary for parallel artery-vein alignment in the mouse retina.

Authors:  Katie Huang; Angela M Crist; Nehal R Patel; Avery Blanks; Kelsey Carter; Ondine Cleaver; Stryder M Meadows
Journal:  Dev Dyn       Date:  2020-02-14       Impact factor: 3.780

3.  NRP1 haploinsufficiency predisposes to the development of Tetralogy of Fallot.

Authors:  Ivan Duran; Jessica Tenney; Carmen M Warren; Anna Sarukhanov; Fabiana Csukasi; Mark Skalansky; Maria L Iruela-Arispe; Deborah Krakow
Journal:  Am J Med Genet A       Date:  2018-01-24       Impact factor: 2.802

Review 4.  The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance.

Authors:  Johannes Wedel; Hironao Nakayama; Nora M Kochupurakkal; Josephine Koch; Michael Klagsbrun; Diane R Bielenberg; David M Briscoe
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

Review 5.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

Review 6.  Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Authors:  Rakesh R Ramjiawan; Arjan W Griffioen; Dan G Duda
Journal:  Angiogenesis       Date:  2017-03-30       Impact factor: 9.596

7.  GIPC proteins negatively modulate Plexind1 signaling during vascular development.

Authors:  Jorge Carretero-Ortega; Zinal Chhangawala; Shane Hunt; Carlos Narvaez; Javier Menéndez-González; Carl M Gay; Tomasz Zygmunt; Xiaochun Li; Jesús Torres-Vázquez
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

8.  NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

9.  NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Mol Carcinog       Date:  2018-12-21       Impact factor: 4.784

10.  VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors.

Authors:  D Grun; G Adhikary; R L Eckert
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.